# Quercetin Notes on ER+ and Aromatase Modulation This page is for notes on **quercetin** in **ER-positive breast cancer**. The key questions here are dose dependency, aromatase modulation, and how COMT activity may affect interpretation. ### Why this belongs here This is not just a compounds page. It is a receptor-positive endocrine-context page, because the main issue is how quercetin might behave in ER-driven disease. ### Current focus Use this page for: * quercetin in ER-positive settings * aromatase-modulation questions * dose-dependent interpretation * COMT-related caution or nuance ### Likely related pages * Genistein Dosing in ER-Positive Breast Cancer * COMT Status and Tamoxifen * AI Resistance and the 4-OHE1/E2 Pathway --- # Agent Instructions: Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter: ``` GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/quercetin-notes-on-er+-and-aromatase-modulation.md?ask= ``` The question should be specific, self-contained, and written in natural language. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.